These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25327003)

  • 21. The recommended goal in the United Kingdom's National Institute for Health and Care Excellence Clinical Guideline 168 for immediate referral of patients with bleeding varicose veins is not being achieved.
    Cragg J; Nyamekye I
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):377-382. PubMed ID: 32726670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid and Foam Sclerotherapy for Spider and Varicose Veins.
    Gibson K; Gunderson K
    Surg Clin North Am; 2018 Apr; 98(2):415-429. PubMed ID: 29502781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines of the First International Consensus Conference on Endovenous Thermal Ablation for Varicose Vein Disease--ETAV Consensus Meeting 2012.
    Pavlović MD; Schuller-Petrović S; Pichot O; Rabe E; Maurins U; Morrison N; Pannier F
    Phlebology; 2015 May; 30(4):257-73. PubMed ID: 24534341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
    Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
    J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.
    Breu FX; Guggenbichler S; Wollmann JC;
    Vasa; 2008 Feb; 37(1):90-5. PubMed ID: 18512547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foam sclerotherapy--a possible option in therapy of varicose veins.
    Kendler M; Wetzig T; Simon JC
    J Dtsch Dermatol Ges; 2007 Aug; 5(8):648-54. PubMed ID: 17659037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.
    Yamaki T
    Ann Vasc Dis; 2010; 3(1):37-45. PubMed ID: 23555386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.
    Watkins MR; Oliver RJ
    Phlebology; 2017 Jul; 32(6):390-396. PubMed ID: 27329670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
    O'Hare JL; Earnshaw JJ
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):232-5. PubMed ID: 17507258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Practical Aspects of Sclerotherapy].
    Stücker M; Dörler M
    Wien Med Wochenschr; 2016 Jun; 166(9-10):302-4. PubMed ID: 27379853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of foam sclerosant inactivation by human whole blood in a laboratory setting.
    Dabbs EB; Dos Santos SJ; Mainsiouw LE; Sheikh AA; Gkantiragas A; Shiangoli I; Watkins MR; Nemchand JL; Whiteley MS
    Phlebology; 2018 Jun; 33(5):338-343. PubMed ID: 28516808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins.
    Myers KA; Jolley D
    Eur J Vasc Endovasc Surg; 2008 Nov; 36(5):602-5. PubMed ID: 18718772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foam sclerotherapy.
    Alder G; Lees T
    Phlebology; 2015 Nov; 30(2 Suppl):18-23. PubMed ID: 26556698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
    King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
    Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study.
    Peterson JD; Goldman MP
    Phlebology; 2012 Mar; 27(2):73-6. PubMed ID: 21926097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany.
    Breu FX; Guggenbichler S; Wollmann JC
    Vasa; 2008 Feb; 37 Suppl 71():1-29. PubMed ID: 18426039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.